Organization
Liling Zhang
1 clinical trial
Clinical trial
Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)Status: Recruiting, Estimated PCD: 2023-12-01